Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PBMs Must Use "Aggressive" Rx Cost Containment In Medicare - Rep. Thomas

Executive Summary

Discussions about the structure of competition under a pharmacy benefit management company administered Medicare drug benefit are irrelevant if PBMs are not able to pursue "aggressive" cost containment, House Ways & Means/Health Subcommittee Chairman Thomas (R-Calif.) said during a May 11 hearing.

You may also be interested in...



PBMs Would Be "Full Partners" With Government Under Thomas Medicare Bill

Pharmaceutical benefit management companies will have the opportunity to become part of a "public-private partnership" with the federal government under Rep. Thomas' (R-Calif.) upcoming Medicare prescription drug bill.

PBMs Would Be "Full Partners" With Government Under Thomas Medicare Bill

Pharmaceutical benefit management companies will have the opportunity to become part of a "public-private partnership" with the federal government under Rep. Thomas' (R-Calif.) upcoming Medicare prescription drug bill.

Medicare Rx Plan In Daschle Bill Would Have 15 PBM-Administered Regions

Medicare prescription drug coverage would be administered by one private pharmacy benefit manager per region in a minimum of 15 different regions according to a bill crafted by Senate Democrats.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS036045

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel